Patient Controlled Analgesia (PCA) Pump Market Share, Size, Financial Summaries Analysis from 2022-2030 | CAGR 5.2%

The Global Patient-Controlled Analgesic Pumps Market Size Was Valued At USD US$ 421.9 Million In 2022 And Is Expected To Expand At A Compound Annual Growth Rate (CAGR) Of 5.2% From 2021 To 2030.

Patient Controlled Analgesia (PCA) Pump Market Overview:

Global Patient Controlled Analgesia (PCA) Pump Market 2022-2030, report discovers comprehensive insights on key manufacturers with share information, market size and projection, key dynamics, growth factors, and new company profiles. The report provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth in the coming years. Patient Controlled Analgesia (PCA) Pump Market opportunities analysis, strategic growth analysis, product launches, marketplace expanding, and technological innovations are also highlighted. The report uncovers Patient Controlled Analgesia (PCA) Pump market size, potential growth, trends and expansion strategies followed by top prominent players.

Get a Sample PDF Copy of Latest Research on Patient Controlled Analgesia (PCA) Pump Market 2022 before purchase:
https://www.contrivedatuminsights.com/request-sample/7767

Patient-controlled analgesia (PCA) is any method that allows patients with pain to administer their own analgesia. The PCA is equipped with a computerized pump that is often used by patients recovering from surgery. Used for postoperative care. Pain control methods provide patients with the power to control their pain. PCA is also beneficial for patients who have difficulty taking medications by mouth. Some of the drugs given by PCA injection are morphine, hydromorphy, and fentanyl. A PCA pump is a computerized pump containing a medication syringe that delivers a small amount of medication in a steady stream. In some cases, a dose is set and additional doses can be administered directly by the patient with the push of a button. Easy to use by parents and nurses for children 6 and under. Key benefits of PCA include improved patient satisfaction, reduced postoperative complications, reduced sedation, improved quality of recovery, and reduced medication use (at dose setting). Disadvantages include the possibility of under- or overdose of the drug, the need for nurse assistance in children under 5 years of age, and difficulty in use in critically ill patients (as it can cause nausea, itching, and constipation).

Some of the key players profiled in the study are

Smiths Group plc, Fresenius Kabi Group, Hospira (Pfizer Inc.), Micrel Medical Devices, Ace Medical Co. Ltd, Terumo Corporation, and Others.

Patient Controlled Analgesia (PCA) Pump Market Segmentation:

By Type:
• Electronic PCA Pump
• Mechanical PCA Pump
• Other

By Applications:
• Diabetes
• Gastroenterology
• Hematology
• Oncology
• Others

By End-Use:
• Hospitals
• Ambulatory Surgical Centers
• Home care settings
• Others

Latest Industry Developments:
• In December 2017, Sheridan Memorial Hospital in Sheridan, Wyoming announced the successful integration of ICU Medical's LifeCare PCA7.0 infusion system with Cerner's core electronic health record (EHR) solution, Cerner Millennium. This announcement marks the first time that a Patient Controlled Pain Relief (PCA) pump has been integrated with Sheridan Memorial through Cerner's EHR technology.
• On April 1, 2022, Smiths Medical announced a partnership with Bainbridge Health. The partnership was focused on providing pharmacy and safety leaders visibility into emerging trends in intravenous drug safety and utilization.
• In January 2022, BD entered into a definitive agreement to acquire Parata Systems for US$1.525 billion.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecasts (2022-2030) of the following regions are covered:
• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• South America (Mexico, Brazil, Argentina, Columbia, Rest of South America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The Asia Pacific Excluding Japan (APEJ) market is dominated by India and China, owing to growing medical demand in both countries, rising prevalence of chronic diseases and awareness of new medical technologies. North America holds the largest market share. However, the recent market share in North America has declined slightly due to device saturation in the region. The European market is expanding due to the aging population and overcoming the economic crisis. Among the end users, the hospital segment dominates the global market and this trend is expected to continue through 2026. Fine-tune parameters based on PCA products, which are more mechanical than regular PCAs, and records are automatically saved. However, it has some disadvantages, such as preparing equipment and drugs, observing the patient's condition, changing various settings, and extracting data.

To Get Complete Access Of The Report Click Here:
https://www.contrivedatuminsights.com/buy/7767

Table of Content of Patient Controlled Analgesia (PCA) Pump Market:
1. Executive Summary
2. Research Methodology
3. Market Outlook
4. Covid-19 Impact On Patient Controlled Analgesia (PCA) Pump Market
5. Patient Controlled Analgesia (PCA) Pump Market Overview, By Segmentation, 2017 - 2030 (USD Million)
6. Patient Controlled Analgesia (PCA) Pump Market Overview, By Geography, 2017 - 2030 (USD Million)
7. North America Patient Controlled Analgesia (PCA) Pump Market Overview, By Countries, 2017 - 2030 (USD Million)
8. Europe Patient Controlled Analgesia (PCA) Pump Market Overview, By Countries, 2017 - 2030 (USD Million)
9. Asia Pacific Patient Controlled Analgesia (PCA) Pump Market Overview, By Countries, 2017 - 2030 (USD Million)
10. Middle East & Africa Patient Controlled Analgesia (PCA) Pump Market Overview, By Countries, 2017 - 2030 (USD Million)
11. South America Patient Controlled Analgesia (PCA) Pump Market Overview, By Countries, 2017 - 2030 (USD Million)
12. Competitive Landscape
13. Key Vendor Analysis
14. Patient Controlled Analgesia (PCA) Pump Market Cost Analysis
15. Industrial Chain, Sourcing Strategy and Downstream Buyers
16. Marketing Strategy Analysis, Distributors/Traders
17. Market Effect Factors Analysis
18. Future Outlook of the Market

Read Detailed Index of full Research Study at@
https://www.contrivedatuminsights.com/product-report/patient-controlled-analgesia-pca-pump-market-insights-2020-global-and-chinese-analysis-and-forecast-to-2027-7767

Why You Should Buy This Report on the Global Patient Controlled Analgesia (PCA) Pump Market:

1. The forecast for the established and growing markets for global Patient Controlled Analgesia (PCA) Pump
2. Use Porter's Five Forces analysis to analyze various market perspectives.
3. The market segment that is anticipated to dominate the Patient Controlled Analgesia (PCA) Pump industry worldwide.
4. Geographical areas that are anticipated to experience the quickest growth over the projection period.
5. Identify the most recent innovations, market shares for global Patient Controlled Analgesia (PCA) Pump and marketing techniques used by the leading industry competitors.

Related Sources: https://www.digitaljournal.com/pr/global-patient-controlled-analgesia-pca-pump-market-is-expected-to-grow-at-a-cagr-of-5-6-during-forecast-period

Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 2152974078
Email: sales@contrivedatuminsights.com

About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.

This release was published on openPR.